Sebi Rejects Gaekwad's Religare Open Offer

By By Rediff Money Desk, New Delhi
Feb 14, 2025 16:08
Sebi has dismissed Digvijay Gaekwad's application for a competing open offer in Religare Enterprises Ltd, citing insufficient financial resources and lack of bonafides.
New Delhi, Feb 14 (PTI) Capital markets regulator Sebi on Friday dismissed an application filed by Digvijay Laxhamsinh Gaekwad seeking an exemption to make a competing open offer for a majority stake in Religare Enterprises Ltd (REL).

Sebi in an order stated that the price offered by Gaekwad was Rs 275 per share in the proposed open offer which was Rs 40 higher than the Burman Group's offer of Rs 235 per share. “The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial obligation for making the competing open offer,” it stated.

The markets watchdog also observed that the "applicant has failed to deposit Rs 600 crore, as directed by the Supreme Court of India vide its order dated February 7, 2025 read with order dated February 12, 2025, which would have shown the applicant's commitment towards making the competing open offer".

In the absence of adequate proof of financial resources required for making the competing open offer, the application by the applicant does not appear to be bonafide. It seems frivolous and aimed solely at hindering the open offer process, the order passed by Sebi's whole time member Ashwani Bhatia said.

"I .... dispose of the application dated February 1, 2025 filed by the applicant," Bhatia said in the order.

The Securities and Exchange Board of India (Sebi) also questioned the role of Gaekwad's merchant banker, PL Capital Markets Pvt Ltd, in doing the due diligence while taking on the assignment of the competing open offer.

"The merchant banker was clueless about the credentials of Gaekwad and was found to have failed to do proper due diligence and KYC of his client before accepting the mandate, the regulator said.

The order came after Gaekwad through his entity (Danny Gaekwad Developments & Investments, Florida) submitted a letter dated January 24, January 26 and February 1, to Sebi requesting to grant requisite exemption under the Takeover rules to allow him to make a competing offer for 55 per cent equity stake of REL, at a price of Rs 275 per equity share.

The Sebi order came a day after Religare Enterprises announced that its executive chairperson Rashmi Saluja ceased to be a director on its board following shareholders' rejection of a proposal seeking her re-appointment.
Source: PTI
Read More On:
sebireligare enterprisesopen offertakeoverdigvijay gaekwad
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Trai Recommends 6 GHz, E, V Band Allocation

Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....

TotalEnergies Sells Stake in Adani Green Energy

TotalEnergies sells 1.74% stake in Adani Green Energy for Rs 2,778 cr. Stake reduced to...

TCS Acquires Coastal Cloud for $700 Million

TCS acquires Coastal Cloud for USD 700 million, strengthening its Salesforce and AI...

JSW Paints Acquires AkzoNobel India Stake

JSW Paints completes acquisition of majority stake in AkzoNobel India, becoming the...

Park Medi World IPO Subscribed 52% on Day 1

Park Medi World''s IPO received 52% subscription on day 1. The Rs 920-crore IPO closes...

Dasnac Invests Rs 2,000 Cr in Noida Luxury Housing

Dasnac to invest Rs 2,000 crore in a luxury housing project, Dasnac Westminster, in...

Nephrocare IPO Subscribed 12% on Day 1

Nephrocare Health Services IPO received 12% subscription on day 1. IPO details, price...

Wakefit IPO Subscribed Over 2 Times

Wakefit''s Rs 1,289-cr IPO was subscribed over 2 times on the final day. Details on...

IAN Group to Deploy USD 100M Alpha Fund by 2027

IAN Group to deploy its USD 100 million IAN Alpha Fund in early-stage startups by 2027....

Corona Remedies IPO Subscribed 137 Times

Corona Remedies IPO subscribed 137.04 times on final day. QIBs subscribed 278.52 times,...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com